Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
7.61M
-
Shares change
-
-168K
-
Total reported value, excl. options
-
$40.1M
-
Value change
-
-$863K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$5.21
Significant Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q1 2022
20 filings reported holding LBPH - LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share as of Q1 2022.
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.61M shares
.
Largest 10 shareholders include Cormorant Asset Management, LP (2.27M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.51M shares), FMR LLC (1.05M shares), MILLENNIUM MANAGEMENT LLC (1.05M shares), FARALLON CAPITAL MANAGEMENT LLC (811K shares), VANGUARD GROUP INC (304K shares), CITIGROUP INC (155K shares), ORBIMED ADVISORS LLC (114K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (70K shares), and Alyeska Investment Group, L.P. (62.5K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.